new_0222_0384|IPSC|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0384|IPSC|Long Name|1|1|Century Therapeutics Inc Total Current Assets (Quarterly) (USD)|Century Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Century Therapeutics Inc Inventories (Quarterly) (USD)|Century Therapeutics Inc Net PP&E (Quarterly) (USD)|Century Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Century Therapeutics Inc Total Liabilities (Quarterly) (USD)|Century Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Century Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Century Therapeutics Inc Total Deposits (Quarterly) (USD)|Century Therapeutics Inc Book Value (Quarterly) (USD)|Century Therapeutics Inc Retained Earnings (Quarterly) (USD)|Century Therapeutics Inc Treasury Stock (Quarterly) (USD)|Century Therapeutics Inc EV to Revenues|Century Therapeutics Inc EV to Earnings|Century Therapeutics Inc EV to Free Cash Flow|Century Therapeutics Inc EV to Assets (Quarterly)|Century Therapeutics Inc PS Ratio|Century Therapeutics Inc PE Ratio|Century Therapeutics Inc Price to Book Value|Century Therapeutics Inc PEG Ratio|Century Therapeutics Inc Debt to Equity Ratio|Century Therapeutics Inc Dividend Yield|Century Therapeutics Inc Shareholder Yield (TTM)|Century Therapeutics Inc Percent of Shares Outstanding Short|Century Therapeutics Inc Total Receivables (Quarterly) (USD)|Century Therapeutics Inc Total Payables (Quarterly) (USD)|Century Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Century Therapeutics Inc Return on Invested Capital|Century Therapeutics Inc Quality Ratio Score|Century Therapeutics Inc Momentum Score|Century Therapeutics Inc Beta (1Y)|Century Therapeutics Inc Sustainable Growth Rate (TTM)|Century Therapeutics Inc Institutional Investor Ownership Percentage|Century Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Century Therapeutics Inc Total Employees (Annual)|Century Therapeutics Inc EPS Diluted (Quarterly) (USD)|Century Therapeutics Inc Shares Outstanding|Century Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Century Therapeutics Inc Ordinary Shares Number (Quarterly)|Century Therapeutics Inc Payout Ratio|Century Therapeutics Inc Quick Ratio (Quarterly)|Century Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Century Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Century Therapeutics Inc Effective Tax Rate (TTM)|Century Therapeutics Inc Return on Equity|Century Therapeutics Inc Net Income (TTM) (USD)|Century Therapeutics Inc Revenue (TTM) (USD)|Century Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Century Therapeutics Inc Revenue (Quarterly) (USD)|Century Therapeutics Inc Gross Profit (Quarterly) (USD)|Century Therapeutics Inc SG&A Expense (Quarterly) (USD)|Century Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Century Therapeutics Inc Net Income (Quarterly) (USD)|Century Therapeutics Inc Net Interest Income (Quarterly) (USD)|Century Therapeutics Inc Price (USD)|Century Therapeutics Inc Total Return Price (USD)|Century Therapeutics Inc Enterprise Value (USD)|Century Therapeutics Inc 30-Day Average Daily Volume|Century Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0384|IPSC|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0384|IPSC||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0384|IPSC||5|5|91|91|0|91|90|91|91|91|0|91|91|0|0|0|1.44242424242|0|0|0|1.43949044586|0|0|1.44242424242|0|15.3571428571|91|91|91|0|0|0|0|0|30.7142857143|91.3333333333|61|91.3333333333|24.3333333333|0|91|0|0|91.3333333333|91.3333333333|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44242424242|1.44242424242|1.44242424242|1.44117647059|0
new_0222_0384|IPSC||6|6|3|3|0|3|1|3|3|3|0|3|3|0|0|0|165|0|0|0|157|0|0|165|0|14|3|3|3|0|0|0|0|0|7|6|1|6|6|0|3|0|0|6|6|0|0|3|0|0|0|0|6|6|6|6|165|165|165|136|0
new_0222_0384|IPSC||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0384|IPSC|202003|202003|202003||||||||||||||||||||||||||||||||||41.8037||-0.2314||||||-0.2314|0||||||||2.05|-9.673|-9.673|0|||||
new_0222_0384|IPSC|202006|202006|202006||||||||||||||||||||||||||||||||||41.8037||-0.366||||||-0.2531|0||||||||2.31|-15.301|-15.301|0.215|||||
new_0222_0384|IPSC|202009|202009|202009||||||||||||||||||||||||||||||||||41.8037||-0.3127||||||-0.3127|0||||||||2.319|-13.07|-13.07|0.061|||||
new_0222_0384|IPSC|202012|202012|202012|78.797|75.753||15.385|9.392|213.188|12.112|201.076||-106.412|-292.342||||||||||||||0.908|8.082|0.001|||||||41.8037||-0.3715|||54.8246|||-0.3715|0|||-53.575|||||2.816|-15.531|-15.531|-0.977|||||
new_0222_0384|IPSC|202103|202103|202103|185.299|182.942||20.657|12.46|377.612|12.912|364.7||-91.557|-310.69||||||||||||||0.137|8.816|0.001|||||||41.8037||-0.44|||54.8246|||-0.44|-0.047|||-62.25|||||2.688|-18.348|-18.348|-0.314|||||
new_0222_0384|IPSC|202104|202103|202103|||||||||||||||||||||||||||||||||||107||||||||||||||||||||||||
new_0222_0384|IPSC|202106|202106|202106|402.611|397.567||46.713||48.033|21.225|26.808||447.597|-333.963||||-14.7306||||3.5662|||0||0.9309|0.137|13.427|0.005||||||48.2261|12.0446|121|-1.93|54.4041||54.4041|||-1.93|-221.952|||-70.222|||||4.088|-23.273|-23.273|-0.252|29.34|29.34|1208.4373||
new_0222_0384|IPSC|202107|202106|202106|||||||||||||||-15.3163||||3.6735|||0||2.2908|||||||||63.5598||||56.4071||||||||||||||||||29.15|29.15|1256.488|339607.9667|
new_0222_0384|IPSC|202108|202106|202106|||||||||||||||-11.7198||||3.0144|||0||3.1323|||||||||67.588||||54.4041||||||||||||||||||24.8|24.8|961.4427|242230.3|
new_0222_0384|IPSC|202109|202109|202109|300.398|295.152||60.663||46.737|19.868|26.869||422.988|-359.972||||-10.0856||||3.2502|||0||2.6262|0.191|11.644|0.005||||||74.95|54.4727||-0.48|54.6414||54.6414|||-0.48|0.467|||-83.161|||||6.282|-26.009|-26.009|-0.182|25.16|25.16|1089.4906|190908.2667|
new_0222_0384|IPSC|202110|202109|202109|||||||||||||||-8.725||||2.9027|||0||3.0458|||||||||74.9726||||||||||||||||||||||22.47|22.47|942.5053|99357.4333|
new_0222_0384|IPSC|202111|202109|202109|||||||||||||||-7.0254||||2.4686|||0||3.1369|||||||||75.1868||||54.6414||||||||||||||||||19.11|19.11|758.9102|81981.8667|
new_0222_0384|IPSC|202112|202112|202112|||||||||||||||-5.3814||||2.0488|||0||4.0377|||||||||75.7587||||||||||||||||||||||15.86|15.86|581.3256|132082.5333|
new_0222_0384|IPSC|202201|202112|202112|||||||||||||||-3.95||||1.6832|||0||4.551|||||||||68.1825||||||||||||||||||||||13.03|13.03|426.6904|127352|
new_0222_0384|IPSC|202202|202112|202112|||||||||||||||-3.5048||||1.5695|||0|||||||||||||||||||||||||||||||||12.15|12.15|378.606|121266.0333|